It’s not just innovator pharma companies concerned with the proposed compromise to Medicare price negotiations and inflation-based rebates
News
Advertisement
Expansion expected to more than double the plant’s footprint
Advertisement
PBM fees and vertical integration are also at the top of the list
CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites
Deal expected to boost firm’s offerings via FDS's delivery system services
Partnership further increases investment firm’s repertoire in healthcare space
Advertisement
Boston area facility will focus heavily on cold chain services
Parties expect improved design and selection of eCOAs in decentralized clinical trials
Latest report shows that demand is above pre-crisis numbers, but there are still capacity constraints
Centers for Disease Control and Prevention endorses Pfizer-BioNTech jab, less than two months after firms presented positive study results
Advertisement
Respondents: Pharmacies are still lagging in the compliance requirements that will be in effect in November 2023
ScriptDrop, Adheris Health collaborate to assist patients with their medication regimens
Anticipated capacity of GMP facility is 60 million vials per year
A total of 116.5 million doses for low- and middle-income nations to arrive in Q2 of 2022
Award will support research based on use of real-world evidence in clinical oncology setting
The latest people news happenings over the past month
Additional equipment to be added to the plant next year
Acquisition reportedly increases AI accessibility across life sciences organizations
Development project features additional manufacturing suites, expansion of storage capabilities
Facility features cell storage for CAR-T cell treatments
mRNA jab maker plans to initially produce 50 million Covid vaccine doses per year
Deal provides ten23 with drug product development, biologic manufacturing experience
Agreement prioritizes ways to better distinguish biological manufacturing processes
Italian facilities will supply EU with up to 85 million doses of Covid jab
Biologics manufacturer to construct new C> facility to support expansion
Facility meets cGMP standards for radiopharmaceutical production
CDTMO’s fourth site further expands its support of cell therapy delivery and access
Second NJ location will complement global HQ, offer plasmid DNA and AAV production services
Non-profit strives for pharma supply chain sustainability
Second Carlsbad location expected to double CDMO’s production capacity
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
2
The Key to Connecting with Patients: Pharma's Market Access Transformation
3
Why Specialty Drugs Dominate Spending, and the Frontline Roles Shaping Patient Access
4
The Next Era of Drug Safety is in Intelligent Action
5